Elizabeth G. O'Farrell
CIK 1744662 · last filed 2026-06-05
Elizabeth G. O'Farrell is a corporate insider who has filed 29 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for LNSR, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$149.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $430.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$430.8K
5
29
-$149.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNSR | Director | 67,368 | $5.82 | $392.1K | $0 | 8 | 2026-06-05 |
| GERN | Director | 33,627 | $1.15 | $38.7K | $64.3K | 12 | 2026-05-26 |
| SGP | Director | — | $18.44 | — | $0 | 1 | 2026-02-09 |
| IKT | Director | — | $1.67 | — | $0 | 3 | 2022-06-28 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 0 | — | — | -$213.7K | 5 | 2020-11-24 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | LNSR | Grant (A) | +17,421 | $0 | EDGAR |
| 2026-05-26 | GERN | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | SGP | Grant (A) | — | $0 | EDGAR |
| 2025-05-28 | LNSR | Grant (A) | +7,374 | $0 | EDGAR |
| 2025-05-22 | GERN | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | GERN | Grant (A) | — | $0 | EDGAR |
| 2024-05-09 | LNSR | Grant (A) | +22,000 | $0 | EDGAR |
| 2023-08-24 | GERN | Buy (P) | +13,186 | $30.1K | EDGAR |
| 2023-06-02 | GERN | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | LNSR | Grant (A) | +9,288 | $0 | EDGAR |